Loading...
Please wait, while we are loading the content...
A comprehensive approach for drug safety assessment.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Li, Albert Bollard Peter J. Klenow Huiyu |
| Copyright Year | 2004 |
| Abstract | A comprehensive, multidisciplinary approach is proposed here for the development of a drug with an acceptable safety profile. Key parameters to be considered for drug safety evaluation based on this comprehensive approach include the following: (1) Pharmacology: Possible toxicity due to drug-target interactions, including interactions with unintended molecular targets, or with molecular targets in unintended organs. (2) Chemistry: Chemical scaffolding and side-chains with safety concerns. (3) Toxicology: Toxicity in animals in vivo, and in relevant animal and human cells in culture. (4) Drug metabolism and pharmacokinetics: Safety concerns due to toxification or detoxification, organ distribution, clearance and pharmacokinetic drug-drug interactions. (5) RISK FACTORS: Physiological, environmental and genetic factors that may enhance a patient's susceptibility. It is proposed that this integrated, multidisciplinary approach to safety evaluation may enhance the accuracy of the prediction of drug safety and thereby the efficiency of drug development. |
| Starting Page | 27 |
| Ending Page | 33 |
| Page Count | 7 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://invitroadmet.com/wp-content/uploads/2018/02/Li-2004-A-comprehensive-approach-to-drug-safety-evaluation.pdf |
| PubMed reference number | 15522259v1 |
| Volume Number | 150 |
| Issue Number | 1 |
| Journal | Chemico-biological interactions |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Adverse reaction to drug Organ Patients drug development |
| Content Type | Text |
| Resource Type | Article |